Home/VaxSyna/Andrew G. Diamos
AG

Andrew G. Diamos

Lead Scientist/Researcher (inferred from publications)

VaxSyna

Therapeutic Areas

VaxSyna Pipeline

DrugIndicationPhase
HSV Vaccine CandidateHerpes Simplex Virus infectionPre-clinical
Zika Virus Vaccine CandidateZika virus infectionPre-clinical
HPV L2 Antigen VaccineHuman Papillomavirus infectionPre-clinical